文献速递乳腺US

基于超声影像组学的列线图预测浸润性乳腺癌脉管侵犯:一项多中心回顾性研究

Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study.
PubMed 文献 · Eur Radiol · 2023-07-31

该多中心回顾性研究纳入3家机构456例连续女性浸润性乳腺癌患者,基于灰阶超声影像组学特征联合临床超声特征构建列线图,用于术前预测脉管侵犯状态,并在训练集、内部验证集和外部验证集中评估预测性能。

要点

  • 列线图整合绝经状态、超声报告腋窝淋巴结状态、后方回声特征及影像组学特征,外部验证AUC达0.95。
  • 列线图预测性能优于单独临床超声模型或影像组学特征模型(p<0.05)。
  • 校准曲线与决策曲线显示列线图校准良好且具有临床实用性。

核心结论

  • 整合影像组学特征、超声及临床特征的列线图对浸润性乳腺癌患者脉管侵犯展现出良好的术前个体化预测能力。

研究设计与样本

  • 多中心回顾性研究,纳入3家机构456例连续女性浸润性乳腺癌患者,机构1和2用于训练(n=320)和测试(n=136),机构3的130例用于外部验证;基于灰阶超声图像提取影像组学特征,采用最小绝对收缩和选择算子及最大相关最小冗余算法筛选特征并构建影像组学特征,采用多变量逻辑回归构建超声影像组学列线图。

诊断标准与关键数值

  • 列线图基于临床超声特征(绝经状态、超声报告淋巴结状态、后方回声特征)和影像组学特征构建,在训练集、内部验证集和外部验证集的AUC分别为0.88(95%CI 0.84-0.91)、0.89(95%CI 0.84-0.94)和0.95(95%CI 0.92-0.99);列线图区分度C-index为0.88(95%CI 0.84-0.91),内部验证为0.88,外部验证为0.95。

临床应用与阅片要点

  • 列线图可用于术前预测浸润性乳腺癌脉管侵犯,整合了绝经状态、超声报告腋窝淋巴结状态、后方回声特征及影像组学特征;校准和决策曲线显示其校准良好且具有临床实用性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate an ultrasound (US) radiomics-based nomogram for the preoperative prediction of the lymphovascular invasion (LVI) status in patients with invasive breast cancer (IBC).

MATERIALS AND METHODS: In this multicentre, retrospective study, 456 consecutive women were enrolled from three institutions. Institutions 1 and 2 were used to train (n = 320) and test (n = 136), and 130 patients from institution 3 were used for external validation. Radiomics features that reflected tumour information were derived from grey-scale US images. The least absolute shrinkage and selection operator and the maximum relevance minimum redundancy (mRMR) algorithm were used for feature selection and radiomics signature (RS) building. US radiomics-based nomogram was constructed by using multivariable logistic regression analysis. Predictive performance was assessed with the receiving operating characteristic curve, discrimination, and calibration.

RESULTS: The nomogram based on clinico-ultrasonic features (menopausal status, US-reported lymph node status, posterior echo features) and RS yielded an optimal AUC of 0.88 (95% confidence interval [CI], 0.84-0.91), 0.89 (95% CI, 0.84-0.94) and 0.95 (95% CI, 0.92-0.99) in the training, internal and external validation cohort. The nomogram outperformed the clinico-ultrasonic and RS model (p < 0.05). The nomogram performed favourable discrimination (C-index, 0.88; 95% CI: 0.84-0.91) and was confirmed in the validation (0.88 for internal, 0.95 for external) cohorts. The calibration and decision curve demonstrated the nomogram showed good calibration and was clinically useful.

CONCLUSIONS: The radiomics nomogram incorporated in the RS and US and the clinical findings exhibited favourable preoperative individualised prediction of LVI.

CLINICAL RELEVANCE STATEMENT: The US radiomics-based nomogram incorporating menopausal status, posterior echo features, US reported-ALN status, and radiomics signature has the potential to predict lymphovascular invasion in patients with invasive breast cancer.

KEY POINTS: • The clinico-ultrsonic model of menopausal status, posterior echo features, and US-reported ALN status achieved a better predictive efficacy for LVI than either of them alone. • The radiomics nomogram showed optimal prediction in predicting LVI from patients with IBC (ROC, 0.88 and 0.89 in the training and validation sets). • A nomogram demonstrated favourable performance (area under the receiver operating characteristic curve, 0.95) and well calibration (C-index, 0.95) in an independent validation cohort (n = 130).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Du Y, Cai M, Zha H, et al. Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study. Eur Radiol. 2023. PMID: 37518678. doi:10.1007/s00330-023-09995-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。